Ignite Creation Date:
2024-05-06 @ 2:07 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04222465
Status:
COMPLETED
Last Update Posted:
2021-10-26
First Post:
2020-01-07
Brief Title:
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA12 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Neoplasms |
Keywords:
| Name | View |
|---|---|
| Advanced ovarian cancer BRCA12 | View |